Item 2.02 - Results of Operations and Financial Condition: The filing reports Molina Healthcare's results of operations and financial condition as of July 22, 2026 Item 9.01 - Financial Statements and Exhibits: The filing includes financial statements and exhibits related to the reported results Company Information: Molina Healthcare, Inc. is a Delaware-incorporated health insurance company (SIC…

Our analysis rates this filing NEUTRAL. Molina Healthcare presents a balanced but cautious picture. The company faces genuine operational headwinds in Q2 2026, primarily driven by medical cost inflation that compressed margins significantly. The 180 basis point MCR deterioration and 74-76% net…

Concern level: ELEVATED (5.2/10). Key factors: Medical Care Ratio deteriorated 180 basis points YoY (90.4% to 92.2%), indicating significant margin compression in core operations; Q2 2026 net income declined 74-76% despite relatively flat revenue, demonstrating operational challenges; G&A ratio increased 50 basis points YoY (6.2% to 6.7%), suggesting cost control challenges beyond medical…

Notable risk changes: Q2 2026 earnings beat with GAAP EPS of $1.19 vs prior year Q2 2025 EPS of $4.75 (significant decline YoY, though Q2 2025 appears to have been an exceptional quarter); Full-year 2026 earnings guidance increased - positive forward guidance signal despite Q2 YoY decline; Medical Care Ratio deteriorated to 92.2% in Q2 2026 from 90.4% in Q2 2025 (180 basis point increase in medical costs as…

Not disclosed in this 8-K filing.

The model predicts MOH will underperform the S&P 500 by about 0.0% over 30 days (model confidence 85%). This is model analysis for research, not investment advice.